These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 14506147

  • 1. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
    Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3606-14. PubMed ID: 14506147
    [Abstract] [Full Text] [Related]

  • 2. Histopathology of BRCA1- and BRCA2-associated breast cancer.
    Honrado E, Benítez J, Palacios J.
    Crit Rev Oncol Hematol; 2006 Jul 01; 59(1):27-39. PubMed ID: 16530420
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
    Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Dopazo J, Rivas C, Benítez J.
    Breast Cancer Res Treat; 2005 Mar 01; 90(1):5-14. PubMed ID: 15770521
    [Abstract] [Full Text] [Related]

  • 4. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.
    Cancer Res; 2003 Jan 15; 63(2):342-7. PubMed ID: 12543786
    [Abstract] [Full Text] [Related]

  • 5. The molecular pathology of hereditary breast cancer.
    Palacios J, Robles-Frías MJ, Castilla MA, López-García MA, Benítez J.
    Pathobiology; 2008 Jan 15; 75(2):85-94. PubMed ID: 18544963
    [Abstract] [Full Text] [Related]

  • 6. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H.
    Clin Cancer Res; 2008 Apr 01; 14(7):1976-83. PubMed ID: 18381935
    [Abstract] [Full Text] [Related]

  • 7. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ.
    Cancer Res; 1999 Apr 15; 59(8):2011-7. PubMed ID: 10213514
    [Abstract] [Full Text] [Related]

  • 8. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
    Loman N, Johannsson O, Bendahl PO, Borg A, Fernö M, Olsson H.
    Cancer; 1998 Jul 15; 83(2):310-9. PubMed ID: 9669814
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
    Noguchi S, Kasugai T, Miki Y, Fukutomi T, Emi M, Nomizu T.
    Cancer; 1999 May 15; 85(10):2200-5. PubMed ID: 10326698
    [Abstract] [Full Text] [Related]

  • 10. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P.
    Clin Cancer Res; 2006 Mar 15; 12(6):1693-700. PubMed ID: 16551851
    [Abstract] [Full Text] [Related]

  • 11. Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.
    van der Groep P, van Diest PJ, Menko FH, Bart J, de Vries EG, van der Wall E.
    J Clin Pathol; 2009 Oct 15; 62(10):926-30. PubMed ID: 19541683
    [Abstract] [Full Text] [Related]

  • 12. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
    Arnes JB, Brunet JS, Stefansson I, Bégin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD.
    Clin Cancer Res; 2005 Jun 01; 11(11):4003-11. PubMed ID: 15930334
    [Abstract] [Full Text] [Related]

  • 13. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry.
    Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, Andrulis IL, O'Malley FP.
    Cancer; 2002 Nov 15; 95(10):2068-75. PubMed ID: 12412159
    [Abstract] [Full Text] [Related]

  • 14. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.
    Cancer; 2003 Jan 01; 97(1):1-11. PubMed ID: 12491499
    [Abstract] [Full Text] [Related]

  • 15. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study.
    Armes JE, Egan AJ, Southey MC, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ.
    Cancer; 1998 Dec 01; 83(11):2335-45. PubMed ID: 9840533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low expression of bcl-2 in Brca1-associated breast cancers.
    Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X.
    Br J Cancer; 2000 Nov 01; 83(10):1318-22. PubMed ID: 11044356
    [Abstract] [Full Text] [Related]

  • 20. BRCA-associated breast cancer: absence of a characteristic immunophenotype.
    Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K.
    Cancer Res; 1998 May 01; 58(9):1839-42. PubMed ID: 9581822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.